Helicos BioSciences, a firm trying to develop a faster way to analyze genes, is planning to go public in a $100 million stock offering. Helicos has received $67 million in financing for its system, the HeliScope, expected to be introduced by year end. If gene sequencing becomes faster and cheaper, it could become a central component of healthcare.